Federal Register / Vol. 76, No. 70 / Tuesday, April 12, 2011 / Notices 20353 

important element of this legislation 

and ACA has established a Prevention 

and Public Health Fund (PPHF) for this 

purpose. Specifically, the legislation 

states in Section 4002 that the PPHF is 

to ‘‘provide for expanded and sustained 

national investment in prevention and 

public health programs to improve 

health and help restrain the rate of 

growth in private and public sector 

health care costs.’’ ACA and the 

Prevention and Public Health Fund 

make improving public health a priority 

with investments to improve public 

health. 

The PPHF states that the Secretary 

shall transfer amounts in the Fund to 

accounts within the Department of 

Health and Human Services to increase 

funding, over the fiscal year 2008 level, 

for programs authorized by the Public 

Health Service Act, for prevention, 

wellness and public health activities 

including prevention research and 

health screenings, such as the 

Community Transformation Grant 

Program, the Education and Outreach 

Campaign for Preventative Benefits, and 

Immunization Programs. 

ACA legislation affords an important 

opportunity to advance public health 

across the lifespan and to reduce health 

disparities by supporting an intensive 

community approach to chronic disease 

prevention and control. Therefore, 

increasing funding available to 

applicants under this FOA using the 

PPHF to continue monitoring the 

effectiveness of vaccines is consistent 

with the purpose of the PPHF, as stated 

above, to provide for an expanded and 

sustained national investment in 

prevention and public health programs. 

Further, the Secretary allocated funds to 

CDC, pursuant to the PPHF, for the 

types of activities this FOA is designed 

to carry out. 

Dated: March 25, 2011. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2011–8653 Filed 4–11–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30-Day–11–10HC] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC 20503 or by fax to (202) 395–5806. 

Written comments should be received 

within 30 days of this notice. 

Proposed Project 

HIV/AIDS Awareness Day Programs— 

New—National Center for HIV/AIDS, 

Viral Hepatitis, STD, and Tuberculosis 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC is requesting OMB approval to 

administer surveys to respondents who 

plan HIV/AIDS day awareness activities 

during the next 3 years. The name and 

dates for the annual HIV/AIDS 

awareness day campaigns are: National 

Black HIV Awareness Day—February 

7th; National Native HIV/AIDS 

Awareness Day—March 20th; National 

Asian and Pacific Islander HIV/AIDS 

Awareness Day—May 19th; and 

National Latino AIDS Awareness Day— 

October 15th. The purpose of the 

surveys is to assess the number and 

types of HIV/AIDS prevention activities 

planned and implemented in 

observance of each of the four noted 

HIV/AIDS awareness day campaigns. 

After the date that each campaign 

occurs, the event planners will be asked 

to respond to a computer-based survey 

to collect qualitative data. They will go 

to the designated websites to review 

information about the campaigns and go 

to the section that allows them to enter 

information about their particular event. 

For example, the event planners will be 

asked to note the kind of events that 

they planned. The survey results are 

necessary to understand how and where 

HIV/AIDS awareness activities are 

planned and implemented. 

These survey results will provide 

important information that will be used 

to develop HIV/AIDS prevention 

activities. The computer-based surveys 

take up to one hour. The surveys and 

interviews are one-time only and will 

not require a follow-up. There is no cost 

to the respondents other than their time. 

The estimated annualized burden hours 

are 375. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Form name Number of 

respondents 

Responses per 

respondent 

Average burden 

per response 

(in hours) 

African-American HIV/AIDS awareness 

day activity planners.

National Black HIV/AIDS Awareness Day 

Evaluation Report.

200 1 1 

Asian and Pacific Islander HIV/AIDS 

awareness day activity planners.

National Asian & Pacific Islander HIV/ 

AIDS Awareness Day Evaluation Report.

15 1 1 

Latino HIV/AIDS awareness day activity 

planners.

National Latino AIDS Awareness Day 

Evaluation Report.

125 1 1 

Native HIV/AIDS awareness day activity 

planners.

National Native HIV/AIDS Awareness 

Day Evaluation Report.

35 1 1 


srobinson on DSKHWCL6B1PROD with NOTICES
20354 Federal Register / Vol. 76, No. 70 / Tuesday, April 12, 2011 / Notices 

Daniel Holcomb, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2011–8650 Filed 4–11–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Intent To Award 

Supplemental Affordable Care Act 

Funding 

Notice of Intent to award 

supplemental Affordable Care Act 

funding to support enhancement of an 

existing laboratory fellowship training 

program through funding opportunity 

CDC–RFA–HM10–1001, ‘‘APHL—CDC 

Partnership for Quality Laboratory 

Practice’’ cooperative agreement. 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice provides public 

announcement of CDC’s intent to use 

Affordable Care Act (ACA) 

appropriations to expand the Emerging 

Infectious Diseases (EID) Laboratory 

Fellowship Program currently 

supported through Funding 

Opportunity CDC–RFA–HM10–1001, 

‘‘APHL–CDC Partnership for Quality 

Laboratory Practice.’’ Funding is 

appropriated under the Affordable Care 

Act (Pub. L. 111–148), Title IV, Section 

4002 (Prevention and Public Health 

Fund). In addition, Under Section 5314, 

Fellowship Training in Public Health 

(Part E of title VII of the Public Health 

Service Act (42 U.S.C. 294n et seq., as 

amended by section 5206, is further 

amended by Sec. 778), CDC is 

authorized to expand existing 

fellowship training programs in the 

critical areas of applied public health 

epidemiology, public health laboratory 

science and public health informatics. 

The CFDA Number for this funding 

opportunity is 93.065. 

CDC will add the following ACA 

Authority to that which is reflected in 

the published Funding Opportunity 

CDC–RFA–HM10–1001: 

Authority: Funding is appropriated under 

the Affordable Care Act (Pub. L. 111–148), 

Title IV, Section 4002 (Prevention and Public 

Health Fund). In addition, Under Section 

5314, Fellowship Training in Public Health 

(Part E of title VII of the Public Health 

Service Act (42 U.S.C. 294n et seq., as 

amended by section 5206, is further amended 

by Sec. 778), CDC is authorized to expand 

existing fellowship training programs in the 

critical areas of applied public health 

epidemiology, public health laboratory 

science and public health informatics. 

Reporting Requirements 

Recipients of the ACA funds through 

this funding opportunity are required to 

comply with the reporting requirements, 

terms and conditions set forth in the 

published version of Funding 

Opportunity CDC–RFA–HM10–1001. 

Award Information: 

Type of Award: Cooperative 

Agreement. 

Approximate Current Fiscal Year 

Funding: $1,000,000 in Affordable Care 

Act (ACA) Funding. 

Anticipated Number of Awards: 1. 

Anticipated Award Date: July 1, 2011. 

Fiscal Year Funds: 2011. 

DATES: The effective date for this action 

is April 12, 2011 and remains in effect 

until the expiration of the project period 

of the PPHF ACA funded application. 

FOR FURTHER INFORMATION CONTACT: 

Elmira Benson, Acting Deputy Director, 

Centers for Disease Control and 

Prevention, 2920 Brandywine Road, 

Atlanta, GA 30341, telephone (770) 

488–2802, e-mail 

Elmira.Benson@cdc.gov. 

SUPPLEMENTARY INFORMATION: On March 

23, 2010, the President signed into law 

the Affordable Care Act (ACA), Public 

Law 111–148. ACA is designed to 

improve and expand the scope of health 

care coverage for Americans. Cost 

savings through disease prevention is an 

important element of this legislation 

and ACA has established a Prevention 

and Public Health Fund (PPHF) for this 

purpose. Specifically, the legislation 

states in Section 4002 that the PPHF is 

to ‘‘provide for expanded and sustained 

national investment in prevention and 

public health programs to improve 

health and help restrain the rate of 

growth in private and public sector 

health care costs.’’ In addition, under 

Section 5314, Fellowship training in 

public health (Part E of title VII of the 

Public Health Service Act (42 U.S.C. 

294n et seq., as amended by section 

5206, is further amended by Sec. 778), 

CDC is authorized to expand existing 

fellowship training programs in the 

critical areas of applied public health 

epidemiology, public health laboratory 

science and public health informatics. 

Supplemental ACA funding, as 

referenced in this notice, will enhance 

the work of national, state and local 

public health laboratories in the U.S. 

through expansion of the Emerging 

Infectious Diseases (EID) Laboratory 

Fellowship Program. The EID 

Fellowship, sponsored by the 

Association of Public Health 

Laboratories (APHL) and CDC and 

funded through a cooperative agreement 

with APHL, trains and prepares 

scientists for careers in public health 

laboratories and supports public health 

initiatives related to infectious disease 

research. The program aims to promote 

quality public health laboratory 

practice, improve public health 

laboratory infrastructure, strengthen the 

public health laboratory system, and 

develop a well-trained public health 

laboratory workforce. Activities that 

promote the development of a welltrained public health laboratory 

workforce are outlined in section 10 of 

the cooperative agreement. Therefore, 

the programmatic activities CDC 

proposes to support with these ACA 

funds are consistent with the intent of 

the Affordable Care Act and Prevention 

and Public Health Fund (PPHF), Section 

4002. 

Dated: March 25, 2011. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2011–8651 Filed 4–11–11; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee. 

Time and Date: 1 p.m.–3:05 p.m., April 28, 

2011. 

Place: The meeting will be held by 

teleconference. Please dial 877–930–8819 

and enter code 1579739. 

Status: Open to the public, limited only by 

the lines available. The public is welcome to 

participate during the public comment 

period. The public comment period is 

tentatively scheduled for 2:55 p.m. to 3 p.m. 

Purpose: The committee will provide 

advice to the CDC Director on strategic and 

other broad issues facing CDC. 

Matters to Be Discussed: The Advisory 

Committee to the Director will review and 

discuss recommendations and reports from 

two subcommittees and one workgroup. The 

Ethics Subcommittee will submit 

recommendations on Ethical Considerations 

for Non-communicable Disease Interventions 

as well as on Ethical Considerations for 

Decision Making Regarding Allocation of 

Mechanical Ventilators during a Severe 


srobinson on DSKHWCL6B1PROD with NOTICES